Sphera Funds Management Ltd.: 13F holdings, Q2 2026
Hedge fund · SEC EDGAR filings (CIK 1496201) · Explore on the interactive board
Sphera Funds Management Ltd. disclosed 97 US equity positions worth $698.8m in its Q2 2026 13F filing (holdings as of June 30, 2026, filed August 14, 2026). Its largest position is TEVA at 7.3% of the reported book, followed by MLYS, TSEM. The top ten holdings are 36.5% of the book, and the portfolio behaves like about 46 equal-weight positions. Versus the prior filing it opened 22 new positions, added to 32, reduced 27 and exited 17. Note: this manager's most recent filing is 3934 quarters behind the newest quarter on file, so these figures are history rather than current positioning.
What does Sphera Funds Management Ltd. own? Top holdings as of June 30, 2026
Change is measured in shares against the previous filing (Q1 2026), so price moves do not read as decisions. This quarter: 22 new, 32 added, 27 reduced, 17 exited.
| # | Stock | Sector | Weight | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|---|
| 1 | TEVA TEVA PHARMACEUTICAL INDS LTD | Healthcare | 7.3% | $50.8m | 1,500,082 | 32% | added |
| 2 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 5.7% | $39.7m | 1,469,971 | 10% | added |
| 3 | TSEM TOWER SEMICONDUCTOR LTD | Technology | 4.0% | $28.2m | 108,265 | -26% | reduced |
| 4 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 3.2% | $22.2m | 1,014,606 | 40% | added |
| 5 | BIIB BIOGEN INC | Healthcare | 3.0% | $20.9m | 96,626 | 4% | added |
| 6 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 2.8% | $19.6m | 588,494 | -27% | reduced |
| 7 | BMRN BIOMARIN PHARMACEUTICAL INC | Healthcare | 2.7% | $18.8m | 328,550 | 135% | added |
| 8 | CYTK CYTOKINETICS INC | Healthcare | 2.7% | $18.7m | 219,987 | 452% | added |
| 9 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 2.6% | $18.3m | 245,346 | 0% | held |
| 10 | COGT COGENT BIOSCIENCES INC | Healthcare | 2.5% | $17.8m | 459,340 | 10% | added |
| 11 | NVMI NOVA LTD | Technology | 2.0% | $13.7m | 25,169 | -53% | reduced |
| 12 | INSM INSMED INC | Healthcare | 1.8% | $12.7m | 118,800 | – | new |
| 13 | MAZE MAZE THERAPEUTICS INC | Healthcare | 1.8% | $12.5m | 417,564 | 84% | added |
| 14 | AZN ASTRAZENECA PLC | Healthcare | 1.7% | $11.9m | 62,530 | 0% | held |
| 15 | SNY SANOFI SA | Healthcare | 1.6% | $11.5m | 269,515 | 0% | held |
| 16 | HELP CYBIN INC | 1.5% | $10.7m | 1,620,753 | 64% | added | |
| 17 | LLY ELI LILLY & CO | Healthcare | 1.4% | $9.6m | 8,040 | -11% | reduced |
| 18 | MDGL MADRIGAL PHARMACEUTICALS INC | Healthcare | 1.3% | $9.4m | 17,419 | 93% | added |
| 19 | TRVI TREVI THERAPEUTICS INC | Healthcare | 1.3% | $9.3m | 499,029 | -13% | reduced |
| 20 | ACAD ACADIA PHARMACEUTICALS INC | Healthcare | 1.3% | $9.0m | 356,534 | 39% | added |
| 21 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 1.3% | $9.0m | 240,868 | -1% | reduced |
| 22 | RYTM RHYTHM PHARMACEUTICALS INC | Healthcare | 1.3% | $8.9m | 80,400 | – | new |
| 23 | ORIC ORIC PHARMACEUTICALS INC | Healthcare | 1.2% | $8.2m | 752,983 | 40% | added |
| 24 | LRCX LAM RESEARCH CORP | Technology | 1.1% | $8.0m | 18,470 | – | new |
| 25 | AMAT APPLIED MATLS INC | Technology | 1.1% | $8.0m | 11,040 | – | new |
| 26 | TNGX TANGO THERAPEUTICS INC | Healthcare | 1.1% | $7.9m | 254,250 | -26% | reduced |
| 27 | NVS NOVARTIS AG | Healthcare | 1.1% | $7.8m | 50,000 | 35% | added |
| 28 | SOLAREDGE TECHNOLOGIES INC | 1.1% | $7.7m | 4,000,000 | 0% | held | |
| 29 | VOR VOR BIOPHARMA INC | Healthcare | 1.1% | $7.7m | 416,417 | 29% | added |
| 30 | ABBV ABBVIE INC | Healthcare | 1.1% | $7.6m | 30,256 | 0% | held |
| 31 | MRK MERCK & CO INC | Healthcare | 1.1% | $7.5m | 58,600 | 21% | added |
| 32 | JNJ JOHNSON & JOHNSON | Healthcare | 1.0% | $7.3m | 28,831 | 0% | held |
| 33 | IDYA IDEAYA BIOSCIENCES INC | Healthcare | 1.0% | $7.3m | 196,408 | – | new |
| 34 | IMTX IMMATICS N.V | Healthcare | 1.0% | $7.3m | 720,057 | 3% | added |
| 35 | NVCT NUVECTIS PHARMA INC | 1.0% | $7.0m | 382,945 | – | new | |
| 36 | PFE PFIZER INC | Healthcare | 1.0% | $6.9m | 286,000 | 54% | added |
| 37 | HRMY HARMONY BIOSCIENCES HLDGS IN | Healthcare | 0.9% | $6.4m | 176,663 | – | new |
| 38 | XENE XENON PHARMACEUTICALS INC | Healthcare | 0.9% | $6.3m | 105,000 | -17% | reduced |
| 39 | CLYM CLIMB BIO INC | Healthcare | 0.9% | $6.3m | 483,747 | 15% | added |
| 40 | ZBIO ZENAS BIOPHARMA INC | 0.8% | $5.9m | 230,834 | 8% | added | |
| 41 | NVO NOVO-NORDISK A S | Healthcare | 0.8% | $5.8m | 120,677 | 0% | held |
| 42 | ELVN ENLIVEN THERAPEUTICS INC | Healthcare | 0.8% | $5.7m | 112,765 | -26% | reduced |
| 43 | PRLD PRELUDE THERAPEUTICS INC | 0.8% | $5.4m | 1,019,832 | 83% | added | |
| 44 | GSK GSK PLC | Healthcare | 0.8% | $5.3m | 102,000 | -16% | reduced |
| 45 | FBRX FORTE BIOSCIENCES INC | 0.8% | $5.3m | 249,693 | 35% | added | |
| 46 | BIOA BIOAGE LABS INC | 0.7% | $5.2m | 213,671 | 147% | added | |
| 47 | SRRK SCHOLAR ROCK HLDG CORP | Healthcare | 0.7% | $5.2m | 94,265 | 0% | held |
| 48 | MSLE SATELLOS BIOSCIENCE INC | 0.7% | $5.1m | 652,590 | 33% | added | |
| 49 | PALI PALISADE BIO INC | Healthcare | 0.7% | $4.7m | 2,257,106 | 30% | added |
| 50 | ELDN ELEDON PHARMACEUTICALS INC | 0.7% | $4.7m | 1,191,187 | -33% | reduced |
What did Sphera Funds Management Ltd. sell? Positions exited since the previous filing
| Stock | Prior weight | Prior value |
|---|---|---|
| AM6 AMICUS THERAPEUTIC | 11.0% | $8.7m |
| CLBT CELLEBRITE DI LTD | 10.9% | $8.7m |
| APLSUSD APELLIS PHARMACEUTICALS INC | 10.9% | $8.6m |
| PANW PALO ALTO NETWORKS INC | 10.6% | $8.5m |
| CAMT CAMTEK LTD | 10.1% | $8.0m |
| SLNOEUR SOLENO THERAPEUTICS INC | 9.1% | $7.2m |
| AMZN AMAZON COM INC | 8.4% | $6.7m |
| AAOI APPLIED OPTOELECTRONICS INC | 7.8% | $6.2m |
| ENPH ENPHASE ENERGY INC | 6.8% | $5.4m |
| ZIM ZIM INTEGRATED SHIPPING SERV | 3.5% | $2.8m |
| SEDG SOLAREDGE TECHNOLOGIES INC | 3.4% | $2.7m |
| IBIT ISHARES BITCOIN TRUST ETF | 2.9% | $2.3m |
| ASND ASCENDIS PHARMA A/S | 2.3% | $1.8m |
| BMY BRISTOL-MYERS SQUIBB CO | 1.3% | $1.1m |
| NICE NICE LTD | 0.8% | $618.7k |
| DTIL PRECISION BIOSCIENCES INC | 0.3% | $220.0k |
| FHTX FOGHORN THERAPEUTICS INC | 0.1% | $58.4k |
Sector mix
| Sector | Weight |
|---|---|
| Healthcare | 76.1% |
| Technology | 8.3% |
| Utilities | 2.1% |
Sectors cover positions whose ticker resolved to a sector; the remainder is unclassified, not cash.
Filing history
How concentrated is Sphera Funds Management Ltd.'s portfolio?
Across every quarter Sphera Funds Management Ltd. has filed, its median largest position is 6.8% of the book and its median top-ten weight is 36.9%, which WhaleCreep classifies as concentrated (the gate is a median largest position of 5%). Of 17.0 completed holding spells, the median lasted 1.0 quarters; 97.0 positions are still open and their final length is unknown.